On 20th, June 2017, the conference of revealing the list of “2016 the Most Influential Enterprise of Chinese Pharmaceutical Industry” (2017 China Medical Health Industry Development Forum) was held by China Federation of Industry and Medical Association in Kun Ming. The national experts, heads of the leading enterprises in pharmaceutical industry, and news media participated in the grand meeting. 

        The list of “2016 the Most Influential Enterprise of Chinese Pharmaceutical Industry” was revealed at the conference. Xi’an Libang Pharmaceutical Co., Ltd. won the title “Top 100 Enterprises of Chinese Pharmaceutical Industry” again. It is the fourth time that Xi’an Libang Pharmaceutical Co., Ltd. has won the prize. Meanwhile, Xi’an Libang Pharmaceutical Co., Ltd. was the entrant for the “2016 Chinese Honest and Law-abiding Pharmaceutical Enterprise”.

        Xi’an Libang Pharmaceutical Co., Ltd. is flourishing with the great support of the government, industry managing department and all sectors of the society. The award Libang has won is a sign of high-level recognition for Libang’s brand awareness, market occupancy, R&D level, business innovation level and law-abiding operation. Besides, the award is also a kind of promotion and encouragement for Libang.

        Libang will develop in reforms and cooperation and advance through crisis and restructuring and create more and more high-quality products in the near future.

 Background Information: All-China Federation of Industry and Commerce Medical Pharmaceutical Chamber is directly under the All-China Federation of Industry and Commerce of immediate. It was established on July 25, 2006. Chamber of Commerce is a private pharmaceutical industry by the Chinese leading enterprises based national trade organization. The purpose of the chamber is to promote the development of human health, and to promote harmonious development of China’s pharmaceutical industry and the reform of various ownership pharmaceutical economies; safeguard the legitimate interests of its members; promote international cooperation and exchange in the pharmaceutical industry.